Latest Manufacturing News

The Environmental Group Limited (ASX – EGL) has landed a $1.9 million contract to design and build its inaugural PFAS treatment plant, marking a key milestone in commercialising its proprietary environmental technology.

HyTerra Limited is advancing its Nemaha Project with the imminent spudding of the McCoy 1 well, moving towards data-driven exploration backed by strategic funding from Fortescue Future Industries Technologies.

Nanoveu’s subsidiary EMASS has reached a key milestone by moving its ECS-DoT AIoT chip into 16nm synthesis, while unveiling a Modular AIoT Development Kit to accelerate edge intelligence adoption.

Nova Eye Medical has reported a record A$28.8 million in revenues for FY25, driven by strong US sales and sustained growth of its flagship iTrack™ Advance device.

Amaero has successfully qualified its C103 and Ti64 metal powders through a collaboration with Auburn University’s NCAME, meeting Velo3D’s standards and paving the way for initial commercial shipments in FY2026.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.

Green Critical Minerals’ proprietary VHD graphite heat sink outperforms traditional materials in computational tests, promising enhanced thermal management for high-power microchips in data centres.

Janus Electric has secured a three-year supply deal with Electrovaya to develop advanced lithium-ion battery packs, promising safer, longer-lasting, and lighter batteries for zero-emission heavy vehicles.

ECS Botanics is supplying its Avani THC10 capsules to a University of Western Australia clinical trial exploring medicinal cannabis as a treatment for obstructive sleep apnoea. The study aims to shed light on THC’s impact on sleep quality and cognitive function.

AML3D has received a pivotal Letter of Intent from the US Navy, outlining plans for additive manufacturing collaboration and significant demand growth through 2030.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

MTM Critical Metals has appointed Gregory L. Bowman, a seasoned U.S. defense and industrial strategy expert, to the advisory board of its U.S. subsidiary Flash Metals USA, aiming to accelerate its critical metals refining technology and deepen ties with U.S. government stakeholders.